एपीए उद्धरण

Geyer, M. B., Rivière, I., Sénéchal, B., Wang, X., Wang, Y., Purdon, T. J., . . . Brentjens, R. J. (2019). Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL. JCI Insight.

शिकागो स्टाइल उद्धरण

Geyer, Mark B., et al. "Safety and Tolerability of Conditioning Chemotherapy Followed By CD19-targeted CAR T Cells for Relapsed/refractory CLL." JCI Insight 2019.

एमएलए उद्धरण

Geyer, Mark B., et al. "Safety and Tolerability of Conditioning Chemotherapy Followed By CD19-targeted CAR T Cells for Relapsed/refractory CLL." JCI Insight 2019.